Ilan Daskal Bio Rad Laboratories, Inc. (BIO) insider trading activity

Ilan Daskal is EVP, Chief Financial Officer of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 2,486 shares of BIO, which is worth approximately $917,135. The most recent transaction as insider was on Sep 02, 2023, when has been sold 269 shares (Bio-Rad A Common Stock) at a price of $394.6 per share, resulting in proceeds of $106,147. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.49K

0% 3M change

0% 12M change

Total Value Held $917,135

Ilan Daskal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2023	SELL Payment of exercise price or tax liability	$106,147 $394.6 p/Share	269 Reduced 9.76%	2,486 Bio-Rad A Common Stock
Sep 02 2023	BUY Exercise of conversion of derivative security	-	542 Added 16.44%	2,755 Bio-Rad A Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$177,175 $394.6 p/Share	449 Reduced 16.87%	2,213 Bio-Rad A Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	1,150 Added 32.19%	2,422 Bio-Rad A Common Stock
Apr 08 2023	SELL Payment of exercise price or tax liability	$113,296 $466.24 p/Share	243 Reduced 14.0%	1,493 Bio-Rad A Common Stock
Apr 08 2023	BUY Exercise of conversion of derivative security	-	700 Added 28.74%	1,736 Bio-Rad A Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$128,668 $478.32 p/Share	269 Reduced 22.01%	953 Bio-Rad A Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	-	541 Added 30.69%	1,222 Bio-Rad A Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$109,892 $486.25 p/Share	226 Reduced 24.92%	681 Bio-Rad A Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	455 Added 33.41%	907 Bio-Rad A Common Stock
Apr 08 2022	SELL Payment of exercise price or tax liability	$153,470 $597.16 p/Share	257 Reduced 36.25%	452 Bio-Rad A Common Stock
Apr 08 2022	BUY Exercise of conversion of derivative security	-	700 Added 49.68%	709 Bio-Rad A Common Stock
Sep 03 2021	SELL Open market or private sale	$221,416 $820.06 p/Share	270 Reduced 96.77%	9 Bio-Rad A Common Stock
Sep 02 2021	SELL Open market or private sale	$447,125 $828.01 p/Share	540 Reduced 98.72%	7 Bio-Rad A Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$222,132 $825.77 p/Share	269 Reduced 49.09%	279 Bio-Rad A Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	$283,384 $262.15 p/Share	1,081 Added 66.36%	548 Bio-Rad A Common Stock
Aug 04 2021	SELL Open market or private sale	$1,729,715 $752.05 p/Share	2,300 Reduced 99.7%	7 Bio-Rad A Common Stock
Aug 04 2021	BUY Exercise of conversion of derivative security	$433,776 $309.84 p/Share	1,400 Added 37.77%	2,307 Bio-Rad A Common Stock
Apr 08 2021	SELL Payment of exercise price or tax liability	$148,057 $592.23 p/Share	250 Reduced 21.61%	907 Bio-Rad A Common Stock
Apr 08 2021	BUY Exercise of conversion of derivative security	-	700 Added 37.7%	1,157 Bio-Rad A Common Stock

Also insider at

NTUS

NATUS MEDICAL INC Healthcare

Director

VIAV

VIAVI SOLUTIONS INC. Technology

EVP, CFO

Ilan Daskal

EVP, Chief Financial Officer

Middleton, WI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account